Bryan Llenas @BryanLlenas
In March the FDA relaxed rules, in an effort to ramp up testing, paving the way for over 90 private antibody tests to go to market. There are now accuracy concerns over unproven tests. https://t.co/X3ChiHfux7 — PolitiTweet.org